Skip to content

Clinical trials

Urogenital Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urogenital Neoplasms Country / region: China Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20202
20212
20221
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status4
Recruiting3
Active, not recruiting1
Completed1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
RenJi Hospital2
Xiaoxiang Chen2
Cancer Foundation, China1
Eli Lilly and Company1
Jinling Hospital, China1
Mabwell (Shanghai) Bioscience Co., Ltd.1
Tianjin Medical University Second Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urogenital Neoplasms9
Neoplasms5
Carcinoma3
Carcinoma, Renal Cell3
Genital Neoplasms, Female3
Kidney Neoplasms3
Neoplasms by Site3
Urologic Neoplasms3
Adnexal Diseases2
Carcinoma, Ovarian Epithelial2

Trials

Showing 26 to 9 of 9. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.